CN102309558A - Traditional Chinese medical preparation for treating hypertension - Google Patents
Traditional Chinese medical preparation for treating hypertension Download PDFInfo
- Publication number
- CN102309558A CN102309558A CN201110266668A CN201110266668A CN102309558A CN 102309558 A CN102309558 A CN 102309558A CN 201110266668 A CN201110266668 A CN 201110266668A CN 201110266668 A CN201110266668 A CN 201110266668A CN 102309558 A CN102309558 A CN 102309558A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medical
- hypertension
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 claims abstract description 78
- 229940079593 drug Drugs 0.000 claims abstract description 30
- 241001077909 Sigesbeckia Species 0.000 claims abstract description 14
- 230000001631 hypertensive effect Effects 0.000 claims description 23
- 210000000582 semen Anatomy 0.000 claims description 17
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 16
- 241000180649 Panax notoginseng Species 0.000 claims description 16
- 241000237636 Pheretima Species 0.000 claims description 16
- 241000237903 Hirudo Species 0.000 claims description 15
- 241000219780 Pueraria Species 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 13
- 230000036772 blood pressure Effects 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 21
- 239000000203 mixture Substances 0.000 abstract description 7
- 206010067482 No adverse event Diseases 0.000 abstract description 2
- 241000143476 Bidens Species 0.000 abstract 1
- 241000201841 Celosia Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000008954 quail grass Nutrition 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 24
- 208000024891 symptom Diseases 0.000 description 15
- 208000002173 dizziness Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 8
- 231100000869 headache Toxicity 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000037396 body weight Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010040007 Sense of oppression Diseases 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 206010047513 Vision blurred Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 208000013220 shortness of breath Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000955 prescription drug Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- FLNXBVJLPJNOSI-UHFFFAOYSA-N 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 FLNXBVJLPJNOSI-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000185686 Apocynum venetum Species 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010048610 Cardiotoxicity Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 235000005013 Pinus cembroides Nutrition 0.000 description 1
- 235000008575 Pinus pinea Nutrition 0.000 description 1
- 240000007789 Pinus pinea Species 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 231100000259 cardiotoxicity Toxicity 0.000 description 1
- 230000007681 cardiovascular toxicity Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229960002544 cloperastine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- -1 vasodilatin Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a pure Chinese medical composition, especially relates to a traditional Chinese medical preparation for treating hypertension. The traditional Chinese medical preparation comprises the following bulk drugs by weight ratio: 20-150 parts of stirred celosia seeds, 20-150 parts of bidens, 10-100 parts of red sage root, 10-150 parts of cortex moutan, 10-60 parts of lumbricus, 10-150 parts of root of kudzu vine, 10-60 parts of leech, 10-120 parts of abalone shell, 10-150 parts of pseudo-ginseng and 10-120 parts of siegesbeckia herba. The traditional Chinese medical preparation is capable of rapidly, steadily reducing blood pressure, reversing the nosogenesis of hypertension, solving the difficult problems of lifetime medicine taking of hypertension patients. The traditional Chinese medical preparation for treating hypertension has characteristics of fast effectiveness, stable blood pressure reduction, unique curative effect and no adverse reaction.
Description
Technical field
The present invention relates to a kind of pure Chinese medicine pharmaceutical composition, particularly a kind ofly be used to treat hypertensive Chinese medicine preparation.
Background technology
Hypertension is one of contemporary modal epidemic diseases, is the disease that a kind of serious harm health influences the human life quality.Someone likens the early high blood pressure disease become " noiseless killer ", makes people's vigilance because it unlike some disease, lets the people agonize earlier, and we often see unexpected apoplexy of somebody or myocardial infarction, just take leave of this world in an instant, and these major parts all are caused by hypertension.Hypertension also is the key factor of bringing out diseases such as heart failure, cerebral infarction, cerebral hemorrhage, renal failure.
What the treatment hypertension was commonly used at present is chemical medicine, mainly contains following several types: diuretic, β-receptor blocking agent, vasodilatin, chemical antihypertensive sheet and FUFANG JIANGYA PIAN etc.Acute attack has certain therapeutic effect to above conventional antihypertensive drugs to hypertension.Though chemical medicine effect rapidly in hypertensive therapeutic process; But side effect is also big; Obviously influence the metabolism of blood-fat and blood sugar etc.; Also possibly damage organs such as the heart, brain, kidney, the diseases such as damage of the hyperlipidemia that these medicines of while cause hypertension, high blood viscosity, target organ do not have tangible improvement effect.Take these depressor and cure the symptoms, not the disease, relapse rate almost is 100% after the drug withdrawal, and patient can only rely on Drug therapy throughout one's life.
Reach treating both the principal and secondary aspects of a disease; The little lasting medicine of toxic and side effects; Make the patient thoroughly away from the purpose of hypertension puzzlement, be difficult to reach through the therapeutic effect of clinical verification chemicals, and the Chinese medicine of China is having significant superiority than chemicals aspect the radical cure illness.Chinese patent medicine depressor commonly used has:
1, Bezoar pill for lowering blood pressure: contain the plurality of Chinese composition, but Calculus Bovis, Borneolum Syntheticum are all cold, so many imapirment of the spleen and stomach are not suitable for taking for a long time.
2, Zhenju Jiangya Tablet: compound preparation, multiple composition, synergism, Western medicine component consumption is few, and its side effect is to disturb the tubular excretion uric acid, causes hyperuricemia; Minority can be brought out the gout outbreak.Low density lipoprotein, LDL and triacylglycerol are raise, and high density lipoprotein reduces, and has to promote atherosclerotic possibility.
3, FUFANG LUOBUMA PIAN: blood pressure is obviously descended, but side effect is that borborygmus, diarrhoea are often arranged, idol has stomachache, xerostomia to wait bitterly for untoward reaction, and asthma, liver pain appear in individual patients; Cardiac toxicity mainly is bradycardia and premature beat.Excessive use can cause calmness, drowsiness, weak etc., can cause that also blood uric acid increases.
Though the Chinese medicine depressor of selling on the market at present is of a great variety; Take the interim blood pressure lowering in back but most medicines also are the patients, can not tackle the problem at its root, so be badly in need of the blood pressure lowering of a kind of ability quick and stable on the market; Need not take medicine for a long time, can better cure hypertensive medicine again.The applicant has applied for the patent of invention of " the hypertensive Chinese medicine preparation of a kind of treatment " in 2010; A kind of hypertensive Chinese medicine preparation that is used to treat is disclosed; Existing applicant researches and develops again and tries out successfully through the patient; Found that the hypertensive Chinese medicine of another kind of treatment newly fills a prescription, had good antihypertensive effect equally.
Summary of the invention
The technical problem that the present invention will solve is: provide a kind of can be fast, steadily blood pressure lowering, reverse hypertension incidence mechanism, solve take medicine the throughout one's life hypertensive Chinese medicine preparation of treatment of difficult problem of hyperpietic, have problems to solve in the above-mentioned prior art.
The technical scheme that solves the problems of the technologies described above is: the hypertensive Chinese medicine preparation of a kind of treatment, and its raw material medicines in portions by weight is counted proportioning and is:
Fry 20～150 parts of Semen Celosiae, 20～150 parts of Herba Bidentis Bipinnatae, 10～100 parts of Radix Salviae Miltiorrhizaes,
10～150 parts of Cortex Moutans, 10～60 parts of Pheretimas, 10～150 parts of Radix Puerariaes,
10～60 parts of Hirudos, 10～120 parts of Concha Haliotidis, 10～150 parts of Radix Notoginseng,
10～120 parts of Herba Siegesbeckiaes.
The hypertensive Chinese medicine preparation of described a kind of treatment, its raw material medicines in portions by weight is counted proportion optimization and is:
Fry 30～130 parts of Semen Celosiae, 20～150 parts of Herba Bidentis Bipinnatae, 15～60 parts of Radix Salviae Miltiorrhizaes,
15～60 parts of Cortex Moutans, 10～60 parts of Pheretimas, 15～40 parts of Radix Puerariaes,
10～40 parts of Hirudos, 10～50 parts of Concha Haliotidis, 10～50 parts of Radix Notoginseng,
10～50 parts of Herba Siegesbeckiaes.
The hypertensive Chinese medicine preparation of described a kind of treatment, its raw material medicines in portions by weight is counted proportion optimization and is:
Fry 30～80 parts of Semen Celosiae, 30～80 parts of Herba Bidentis Bipinnatae, 20～50 parts of Radix Salviae Miltiorrhizaes,
20～50 parts of Cortex Moutans, 10～30 parts of Pheretimas, 10～35 parts of Radix Puerariaes,
10～30 parts of Hirudos, 10～30 parts of Concha Haliotidis, 10～30 parts of Radix Notoginseng,
10～30 parts of Herba Siegesbeckiaes.
The hypertensive Chinese medicine preparation of described a kind of treatment, its raw material medicines in portions by weight is counted proportion optimization and is:
Fry 80～150 parts of Semen Celosiae, 40～70 parts of Herba Bidentis Bipinnatae, 40～70 parts of Radix Salviae Miltiorrhizaes,
40～70 parts of Cortex Moutans, 40～60 parts of Pheretimas, 20～50 parts of Radix Puerariaes,
20～50 parts of Hirudos, 30～60 parts of Concha Haliotidis, 30～60 parts of Radix Notoginseng,
30～60 parts of Herba Siegesbeckiaes.
The hypertensive Chinese medicine preparation of described a kind of treatment, its raw material medicines in portions by weight is counted proportion optimization and is:
Fry 40～70 parts of Semen Celosiae, 20～50 parts of Herba Bidentis Bipinnatae, 20～60 parts of Radix Salviae Miltiorrhizaes,
15～60 parts of Cortex Moutans, 15～60 parts of Pheretimas, 20～40 parts of Radix Puerariaes,
20～40 parts of Hirudos, 25～50 parts of Concha Haliotidis, 30～50 parts of Radix Notoginseng,
10～50 parts of Herba Siegesbeckiaes.
The hypertensive Chinese medicine preparation of described a kind of treatment, its raw material medicines in portions by weight is counted proportion optimization and is:
Fry 60 parts of Semen Celosiae, 20 parts of Herba Bidentis Bipinnatae, 20 parts of Radix Salviae Miltiorrhizaes,
15 parts of Cortex Moutans, 15 parts of Pheretimas, 25 parts of Radix Puerariaes,
20 parts of Hirudos, 25 parts of Concha Haliotidis, 30 parts of Radix Notoginseng,
10 parts of Herba Siegesbeckiaes.
The characteristic of various crude drug is following among the present invention:
Fry Semen Celosiae: function cures mainly: liver heat removing makes eye bright nebula removing.Be used for the liver-heat conjunctival congestion, the nebula of looking unfamiliar film, blurring of vision, dizziness due to liver-fire.
Herba Bidentis Bipinnatae: function cures mainly: relieving the exterior syndrome heat clearing away, detoxifcation, dissipating blood stasis.Meridian distribution of property and flavor: hardship, flat.
Radix Salviae Miltiorrhizae: function cures mainly: stasis-dispelling and pain-killing, and promoting blood circulation to restore menstrual flow, relieving restlessness clears away heart-fire.Meridian distribution of property and flavor: hardship is slightly cold.GUIXIN, Liver Channel.
Cortex Moutan: function cures mainly: the pathogenic heat attacking blood system in febrile diseases, send out speckle, and infantile convulsion is told, is defeated in battle, is had blood in stool, the hectic fever due to YIN-deficiency consumptive fever, amenorrhea, lump in the abdomen, carbuncle and ulcer is pounced on damage.
Pheretima: function cures mainly: heat clearing away, suppressing the hyperactive liver, Zhichuan, logical Lip river.High fanatical dry, convulsion with spasms, headache due to pathogenic wind-heat, conjunctival congestion, hemiplegia etc.Extract of LEF has the good effect that cloperastine is breathed heavily of deciding.
Radix Puerariae: function cures mainly: expelling pathogenic factors from muscles for reducing heat, promote the production of body fluid rash, yang invigorating antidiarrheal.Meridian distribution of property and flavor: sweet, hot, cool.Return spleen, stomach warp.
Hirudo: function cures mainly: removing blood stasis, removing blood stasis stimulates the menstrual flow.
The stone pine torch: function cures mainly: clearing away heat to improve acuity of vision, loosening bowel to relieve constipation.Meridian distribution of property and flavor: sweet, bitter, salty, be slightly cold.GUIXIN, spleen, lung meridian.
Radix Notoginseng: function cures mainly: hemostasis, dissipating blood stasis, detumescence, analgesic therapy.
Herba Siegesbeckiae: function cures mainly: wind-damp dispelling, relaxing muscles and tendons and activating QI and blood in the collateral is given birth to and is used heat-clearing and toxic substances removing.
Theory of Chinese medical science thinks that hypertension mainly is the imbalance of YIN and YANG by the heart, liver, renal function, adds exopathogen such as experiencing wind, heat, poison invasion and attack, hands over knot mutually with the intravital expectorant of people, the stasis of blood, and due to various factors interacts.Therefore, through suppressing the hyperactive liver and subsiding YANG, vital energy regualting and blood circulation-promoting, kidney is supported in YIN nourishing, and the heat clearing away blood stasis dispelling is the hypertensive effective way of treatment.In numerous medicines, the medicine of simple blood pressure lowering is not ideal medicine, and ideal medicine should be in blood pressure lowering, can reverse its pathological process, prevents and treats the generation of complication, and should not have obvious toxic and side effects.The present invention is based on above-mentioned theory, collects multiple rare Chinese medicine and utilizes modern technologies to develop.Its distinctive antihypertensive compositions can combine with the target cell of whole body blood vessel, organ, tissue, and the abnormal hemodynamics situation of body is corrected voluntarily.Pharmacodynamic study shows that the present invention has suppressing the hyperactive liver and subsiding YANG; Kidney is supported in YIN nourishing; Vital energy regualting and blood circulation-promoting, heat clearing away blood stasis dispelling, clear stagnating; Effects such as spasmolytic blood pressure lowering, capable of lowering blood pressure and decreasing blood fat, fall that blood is sticking, dizziness that vessel softening, blood lipid regulation, eliminating blood poison, treatment hypertension cause, headache, cardiopalmus, uncomfortable in chest, dim eyesight, tinnitus has unique curative effect.
The present invention takes through 300 multidigit patients, and effective percentage has reached 98%, cures the back and has not seen the phenomenon that recurrence is arranged at present.This product has unique curative effect and higher cure rate to treatment hypertension, and general patient only needed take effect in 3 days, and just can cure three courses of treatment, need not to take medicine for a long time no significant side effects.The present invention can be fast, steadily blood pressure lowering, reverses hypertension incidence mechanism, solves the difficult problem that the hyperpietic takes medicine throughout one's life.The present invention treat hypertension have instant effect, steadily blood pressure lowering, special effect, characteristics such as have no adverse reaction.
The specific embodiment
Embodiment one:
The hypertensive Chinese medicine preparation of a kind of treatment, it comprises by following parts by weight proportion raw material medicine:
Monarch drug is fried 60 parts of Semen Celosiae, 20 parts of ministerial drug Herba Bidentis Bipinnatae, and 20 parts of ministerial drug Radix Salviae Miltiorrhizaes,
15 parts of monarch drug Cortex Moutans, 15 parts of ministerial drug Pheretimas, 25 parts of ministerial drug Radix Puerariaes,
20 parts of ministerial drug Hirudos, 25 parts of ministerial drug Concha Haliotidis, 30 parts of ministerial drug Radix Notoginseng,
10 parts of Jun Yao Herba Siegesbeckiaes.
The method for preparing of above-mentioned Chinese medicine composition is:
A, water intaking trematodiasis, Pheretima, Radix Notoginseng powder is broken into fine powder;
B, get Herba Bidentis Bipinnatae, Radix Salviae Miltiorrhizae, Cortex Moutan, Radix Puerariae decocte with water secondary, each 1.5 hours, add 3.5 times of amounts of water for the first time, add 3 times of amounts of water for the second time, collecting decoction filters, and it is 1.24～1.26 (90 ℃) that filtrating is concentrated into relative density; Get the stir-fry Semen Celosiae, Herba Siegesbeckiae, Concha Haliotidis is ground into coarse powder, adds alcohol reflux and puts coldly in 1.5 hours, adds 4 times of amounts of water, stirs, and leaves standstill 24 hours, and getting supernatant concentration to relative density is 1.20～1.28 (80 ℃), the concentrated solution of above-mentioned seven flavor medicine is processed granule, drying.
C, the Hirudo that steps A is made, Pheretima, the granule mixing that Radix Notoginseng fine powder and step B make, compacting, the bag film-coat promptly gets sheet.Also can be made into the ball shape or the Chinese medicine preparation of other form.
Embodiment two～embodiment eight:
The hypertensive Chinese medicine preparation of a kind of treatment, the crude drug of said composition and parts by weight see also subordinate list one, and the method for preparing of this Chinese medicine composition is identical with embodiment one.
Subordinate list one
Stir-fry Semen Celosiae described in the various embodiments of the present invention is meant the Semen Celosiae for preparing through parch, and its preparation process is put in the preheating parch container for getting clean Semen Celosiae, with slow fire heating, fries to explosion is arranged, and is inner light yellow, and during effusion fragrance, takes out the cold of drying in the air.
Through clinical trial case case curative effect of the present invention is described further below.
1, patient Li Xiansheng, man, 61 years old; Suffered from III phase hypertension 9 years, blood pressure: 200/120mmHg, concurrent coronary heart disease; Often headache, insomnia, retinal hemorrhage took place in nearly 2 years again, audition also obviously descends, and various Chinese medicine and western medicine were all used; Blood pressure is fluctuated all the time, but also can control basically, is exactly can not drug withdrawal.Listen a ward mate to introduce and find my company, observe his figure, obviously become thin, some is withered for skin; In conjunction with above-mentioned symptom, dialectical is the liver-yang hyperactivity spleen-deficient, because secular depression of liver-QI causes excessive rising of liver-YANG; The prosperous victory of edema with the liver involved and restrain spleen soil causes insufficiency of the spleen and fortune water food not, and is insufficiency of the spleen and the blood of not uniting was taken my company blood pressure lowering prescription of the present invention afterwards; After the course of treatment, headache obviously alleviated than in the past, and blood pressure also no longer raises, and takes three courses of treatment; Blood pressure stabilization is between the 130/85mmHg, and various complication also disappear thereupon, and drug withdrawal is not recurred so far.
2, the patient relaxes certain, the woman, and 49 years old, the patient had a headache for a long time, dizziness, tinnitus, cardiopalmus, dim eyesight, aprosexia; Go to pharmacy to buy medicine voluntarily, use sphygomanometer to record blood through the employee of pharmacy and be 110/150mmHg, advise that she has bought depressor and has taken voluntarily, but effect be not fine; Above-mentioned symptom off and on, in the recent period headache, dizzy symptom have obviously and increase the weight of, and make referrals to my company by friend, inspection: blood pressure: 120/168mmHg; Body weight 68kg belongs to the moderate obesity, and the patient this situation occurs and had 18 years, and the initial stage also is not clearly; In recent years the living condition makes moderate progress, and meat is more, and activity is also less, and weight increase is very fast; In conjunction with the sign situation, be diagnosed as stagnation of phlegm-damp in middle-JIAO type hypertension, take my company blood pressure lowering prescription of the present invention; The hypertension index obviously descends, and medication is after 10 days, many transference cures such as dizziness and blurred vision, sensation of oppression over the chest with shortness of breath more than half; After three courses of treatment, blood pressure returns to 87/138mmHg, transference cures such as dizziness, headache; Can normally be engaged in work, production at present, not see recurrence at present more than a year.
3, patient Hu Xiansheng, 42 years old, health check-up found to suffer from hypertension before 2 years, begins not take notice of; Have some depressor once in a while, aftersensation memory obviously descended in 1 year, and ophthalmic is pain often, to examination in hospital hypertension II type; Find my company through friend's introduction, see his sign, the about 158mm of height, body weight 60kg; Patient's readme, because family's pressure is big, often overtime work, life does not have rule; Before feeling that memory obviously is not so good as nearly half a year, see that often computer, TV feel that all ophthalmalgia sheds tears dizziness and blurred vision.Comprehensive dialectical is that liver blood loses stagnation of dampness due to deficiency of the spleen type disease.Took my company blood pressure lowering prescription drug of the present invention afterwards after three courses of treatment, above-mentioned symptom obviously improves, and all are normal through hospital's health check-up, does not have bounce-back so far.
4, patient Lin Xiansheng, the man, 53 years old, oneself had 9 years dizzy symptom to occur; Just begun not arouse attention, had a dizzy spell in the recent period and increase the weight of gradually, sensation of oppression over the chest with shortness of breath, activity is often unable to do what one wishes; Remove examination in hospital: the blood pressure inspection is 125/190mmHg, and body weight 80kg, cholesterol in the serum and triglyceride raise and exceed one times of normal value; Be diagnosed as hypertension, take metoprolol, but effect not clearly to it.Make referrals to my company through friend afterwards, and listened him to introduce, more owing to treating with courtesy in recent years on the business field, the food and drink wine of often entertaining guests; Weight increase was obvious in nearest 1 year, in conjunction with above-mentioned clinical symptoms, should be the stagnation of phlegm-damp in middle-JIAO type of differential diagnosis in tcm, advised that it is with my company blood pressure lowering prescription of the present invention; After the medication 10 days, many symptoms such as dizziness and blurred vision, sensation of oppression over the chest with shortness of breath obviously alleviate, sensation of oppression over the chest with shortness of breath has also disappeared, and whole body energetically; Spirit is obviously improved, next serve on two the course of treatment medicine, all transference cures, electrocardiogram check; Blood supply of cardiac muscle is normal, and when paying a return visit in the recent period, he says nearly 1 year and do not take depressor that blood pressure is normal.
5, patient Wu Xiansheng, man 44 years old, certain schoolman, ill 5 years, to feel often to have palpitation, breathe hard, stomach is often latent painful, and some complication appear in heart and brain, medication repeatedly in the past few years, drug withdrawal all the time is bounce-back just.Listen the colleague of unit to introduce, find my company, through sphygomanometer inspection, blood pressure: 165/128mmHg; Body weight 70kg, color and luster is regreted secretly on the face, and the arm epithelium has several places ecchymosis, comprehensively its symptom; Dialectical is qi stagnation and blood stasis type hypertension, advises it and takes my company blood pressure lowering of the present invention prescription, takes three courses of treatment of this prescription drug, and facial color and luster obviously improves; The skin ecchymosis is eliminated, and the symptom of having palpitation, breathe hard also occurs again, follows up a case by regular visits to afterwards, adheres to physical training in nearly 1 year; Noticed in the life also that much the mental status is fine, occurs original symptom never again.
6, patient Mr. Gao, the man, 59 years old, nearly 12 years of hypertension, renal dysfunction 1 year, maximal blood pressure reaches 210/130mmHg, the time with the headache, dizziness, take depressor, but controlling of blood pressure is undesirable.Listen friend to introduce and find my company, fat aspectual character is obvious, and body weight has reached 90kg, and two lower limb have tangible edema impression; Abdominal part is obviously greater than the normal person, and in conjunction with all symptoms, dialectical is deficiency of yang of liver and kidney, stagnation of phlegm-damp in middle-JIAO; Qi depression to blood stasis disease, suggestion are taken my company blood pressure lowering prescription of the present invention, after the course of treatment; Symptom is obviously improved, and the effective blood vessel dilating of this prescription institute medicament has reduced the fat in the blood; Improved the permeability of blood vessel, blood pressure is reduced, fundamentally solved the continuation infringement of hypertension kidney.After treating 3 courses of treatment, sb.'s illness took a favorable turn, and two lower limbs edema disappear, and nauseating, symptoms of emesis disappears, and diet increases, weak doing well,improving, and other transference cure, blood pressure is normal.When seeing him, condition is fine, listens him to say these 2 years and has also noted physical exercise, has controlled diet, and phychology has also been relaxed, and former symptom did not occur again.
Claims (6)
1. treat hypertensive Chinese medicine preparation for one kind, it is characterized in that: its raw material medicines in portions by weight is counted proportioning and is:
Fry 20～150 parts of Semen Celosiae, 20～150 parts of Herba Bidentis Bipinnatae, 10～100 parts of Radix Salviae Miltiorrhizaes,
10～150 parts of Cortex Moutans, 10～60 parts of Pheretimas, 10～150 parts of Radix Puerariaes,
10～60 parts of Hirudos, 10～120 parts of Concha Haliotidis, 10～150 parts of Radix Notoginseng,
10～120 parts of Herba Siegesbeckiaes.
2. the hypertensive Chinese medicine preparation of a kind of treatment according to claim 1, it is characterized in that: its raw material medicines in portions by weight is counted proportioning and is:
Fry 30～130 parts of Semen Celosiae, 20～150 parts of Herba Bidentis Bipinnatae, 15～60 parts of Radix Salviae Miltiorrhizaes,
15～60 parts of Cortex Moutans, 10～60 parts of Pheretimas, 15～40 parts of Radix Puerariaes,
10～40 parts of Hirudos, 10～50 parts of Concha Haliotidis, 10～50 parts of Radix Notoginseng,
10～50 parts of Herba Siegesbeckiaes.
3. the hypertensive Chinese medicine preparation of a kind of treatment according to claim 1, it is characterized in that: its raw material medicines in portions by weight is counted proportioning and is:
Fry 30～80 parts of Semen Celosiae, 30～80 parts of Herba Bidentis Bipinnatae, 20～50 parts of Radix Salviae Miltiorrhizaes,
20～50 parts of Cortex Moutans, 10～30 parts of Pheretimas, 10～35 parts of Radix Puerariaes,
10～30 parts of Hirudos, 10～30 parts of Concha Haliotidis, 10～30 parts of Radix Notoginseng,
10～30 parts of Herba Siegesbeckiaes.
4. the hypertensive Chinese medicine preparation of a kind of treatment according to claim 1, it is characterized in that: its raw material medicines in portions by weight is counted proportioning and is:
Fry 80～150 parts of Semen Celosiae, 40～70 parts of Herba Bidentis Bipinnatae, 40～70 parts of Radix Salviae Miltiorrhizaes,
40～70 parts of Cortex Moutans, 40～60 parts of Pheretimas, 20～50 parts of Radix Puerariaes,
20～50 parts of Hirudos, 30～60 parts of Concha Haliotidis, 30～60 parts of Radix Notoginseng,
30～60 parts of Herba Siegesbeckiaes.
5. the hypertensive Chinese medicine preparation of a kind of treatment according to claim 1, it is characterized in that: its raw material medicines in portions by weight is counted proportioning and is:
Fry 40～70 parts of Semen Celosiae, 20～50 parts of Herba Bidentis Bipinnatae, 20～60 parts of Radix Salviae Miltiorrhizaes,
15～60 parts of Cortex Moutans, 15～60 parts of Pheretimas, 20～40 parts of Radix Puerariaes,
20～40 parts of Hirudos, 25～50 parts of Concha Haliotidis, 30～50 parts of Radix Notoginseng,
10～50 parts of Herba Siegesbeckiaes.
6. the hypertensive Chinese medicine preparation of a kind of treatment according to claim 1, it is characterized in that: its raw material medicines in portions by weight is counted proportioning and is:
Fry 60 parts of Semen Celosiae, 20 parts of Herba Bidentis Bipinnatae, 20 parts of Radix Salviae Miltiorrhizaes,
15 parts of Cortex Moutans, 15 parts of Pheretimas, 25 parts of Radix Puerariaes,
20 parts of Hirudos, 25 parts of Concha Haliotidis, 30 parts of Radix Notoginseng,
10 parts of Herba Siegesbeckiaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102666687A CN102309558B (en) | 2011-09-09 | 2011-09-09 | Traditional Chinese medical preparation for treating hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102666687A CN102309558B (en) | 2011-09-09 | 2011-09-09 | Traditional Chinese medical preparation for treating hypertension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102309558A true CN102309558A (en) | 2012-01-11 |
| CN102309558B CN102309558B (en) | 2013-02-13 |
Family
ID=45423366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011102666687A Active CN102309558B (en) | 2011-09-09 | 2011-09-09 | Traditional Chinese medical preparation for treating hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102309558B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103584095A (en) * | 2013-11-04 | 2014-02-19 | 任方永 | Health-care drink for treating hypertention and preparation method of health-care drink |
| CN103653237A (en) * | 2013-11-05 | 2014-03-26 | 李文彩 | Health-care cigarette capable of reducing hypertension, hyperglycemia and hyperlipidemia |
| CN103830436A (en) * | 2014-03-07 | 2014-06-04 | 大连圣弘医药有限公司 | Traditional Chinese medicine composition for treating hypertension and preparation method thereof |
| CN106138890A (en) * | 2016-08-18 | 2016-11-23 | 宋业琳 | A kind of Chinese medicine preparation treating hypertension and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1437959A (en) * | 2002-02-10 | 2003-08-27 | 杨志东 | Chinese prepartory for treating cardiovascular and cerebrovascular disease and preparation method |
| CN101129817A (en) * | 2007-09-26 | 2008-02-27 | 王福春 | Chinese medicine formulation for treating hypertension and method of producing the same |
-
2011
- 2011-09-09 CN CN2011102666687A patent/CN102309558B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1437959A (en) * | 2002-02-10 | 2003-08-27 | 杨志东 | Chinese prepartory for treating cardiovascular and cerebrovascular disease and preparation method |
| CN101129817A (en) * | 2007-09-26 | 2008-02-27 | 王福春 | Chinese medicine formulation for treating hypertension and method of producing the same |
Non-Patent Citations (3)
| Title |
|---|
| 吴兴田: "水蛭的研究近况及其在高血压性脑出血的应用", 《陕西中医》 * |
| 张哲锋等: "《豨莶草化学成分与药理活性的研究进展》", 《中医药信息》 * |
| 张朝阳: "降压中药的有关研究进展", 《内蒙古中医药》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103584095A (en) * | 2013-11-04 | 2014-02-19 | 任方永 | Health-care drink for treating hypertention and preparation method of health-care drink |
| CN103584095B (en) * | 2013-11-04 | 2015-12-09 | 任方永 | Treat hypertensive health beverages and preparation method thereof |
| CN103653237A (en) * | 2013-11-05 | 2014-03-26 | 李文彩 | Health-care cigarette capable of reducing hypertension, hyperglycemia and hyperlipidemia |
| CN103830436A (en) * | 2014-03-07 | 2014-06-04 | 大连圣弘医药有限公司 | Traditional Chinese medicine composition for treating hypertension and preparation method thereof |
| CN106138890A (en) * | 2016-08-18 | 2016-11-23 | 宋业琳 | A kind of Chinese medicine preparation treating hypertension and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102309558B (en) | 2013-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101062377B (en) | Adhesive plaster for diminishing inflammation, expelling wind and cold | |
| CN1628760A (en) | Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease | |
| CN101979020B (en) | Chinese medicinal preparation for treating high blood pressure | |
| CN102309558B (en) | Traditional Chinese medical preparation for treating hypertension | |
| CN103749824B (en) | A kind of Herb Gynostemmae Pentaphylli blood sugar lowering blood pressure depressing health tea and preparation method thereof | |
| CN106668607A (en) | Traditional Chinese medicine for treating gout | |
| CN102600434B (en) | Compound mixture for curing cervical vertigo | |
| CN104248717B (en) | A kind of foot-bath traditional Chinese medicine composition for treating hypertension and preparation method thereof | |
| CN103830482B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of apoplexy | |
| CN104288303A (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
| CN106729518A (en) | A kind of tea beverage of hypotensive and preparation method and application | |
| CN102579688B (en) | Blood pressure reducing chrysanthemum and dogbane leaf traditional Chinese medicine preparation | |
| CN104606571A (en) | Fresh spinach root tea substituted drink with effects of helping produce saliva and slaking thirst and preparation method thereof | |
| CN103877356B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of myocardial infarction | |
| CN101884735B (en) | Medicament for treating dyslipidemia and preparation method thereof | |
| CN104095913B (en) | One kind plays both sides of the street pharmaceutical composition and preparation method thereof | |
| CN103961603B (en) | Traditional Chinese medicine preparationcapable of reducing blood fat and freeing vessels | |
| CN102626503B (en) | Chinese medicinal oral liquid for smoothing heart and enhancing intelligence | |
| CN101229296A (en) | Medicine compounds for treating hypertension, heart disease and angina | |
| CN105944042A (en) | Traditional Chinese medicine for preventing coronary heart disease | |
| CN104042676B (en) | It is a kind of to treat Chinese medicine composition of coronary heart disease and preparation method thereof | |
| CN104096112A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
| CN104799276A (en) | Panax notoginseng and gastrodia elata powder for promoting normal circulation of blood and thrombolysis, and preparation method thereof | |
| CN104491086B (en) | A kind of Chinese medicine composition for treating blood supply insufficiency of brain | |
| CN104223090B (en) | The herbal cuisine preparation for the treatment of diabetes and method for making |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Hypertension treating traditional Chinese medicine preparation and its preparing process Effective date of registration: 20130827 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: Guangxi Zhengtang Pharmaceutical Co., Ltd|Liu Jingming Registration number: 2013450000006 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20140912 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: Guangxi Zhengtang Pharmaceutical Co., Ltd|Liu Jingming Registration number: 2013450000006 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Hypertension treating traditional Chinese medicine preparation and its preparing process Effective date of registration: 20140918 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: Guangxi Zhengtang Pharmaceutical Co., Ltd|Liu Jingming Registration number: 2014450000002 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160802 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: Guangxi Zhengtang Pharmaceutical Co., Ltd|Liu Jingming Registration number: 2014450000002 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Hypertension treating traditional Chinese medicine preparation and its preparing process Effective date of registration: 20180724 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: Guangxi Zhengtang Pharmaceutical Product Co., Ltd.|Liu Jingming Registration number: 2018450000019 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200723 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: GUANGXI ZHENGTANG PHARMACEUTICAL PRODUCT Co.,Ltd.|Liu Jingming Registration number: 2018450000019 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A traditional Chinese medicine preparation for treating hypertension Effective date of registration: 20201119 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: GUANGXI ZHENGTANG PHARMACEUTICAL PRODUCT Co.,Ltd.|Liu Jingming Registration number: Y2020450000045 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |